These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29188511)

  • 1. AAV Gene Augmentation Therapy for CRB1-Associated Retinitis Pigmentosa.
    Alves CH; Wijnholds J
    Methods Mol Biol; 2018; 1715():135-151. PubMed ID: 29188511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of CRB2 in Müller glial cells modifies a CRB1-associated retinitis pigmentosa phenotype into a Leber congenital amaurosis phenotype.
    Quinn PM; Mulder AA; Henrique Alves C; Desrosiers M; de Vries SI; Klooster J; Dalkara D; Koster AJ; Jost CR; Wijnholds J
    Hum Mol Genet; 2019 Jan; 28(1):105-123. PubMed ID: 30239717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining Phenotype, Tropism, and Retinal Gene Therapy Using Adeno-Associated Viral Vectors (AAVs) in New-Born Brown Norway Rats with a Spontaneous Mutation in
    Boon N; Alves CH; Mulder AA; Andriessen CA; Buck TM; Quinn PMJ; Vos RM; Koster AJ; Jost CR; Wijnholds J
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of CRB2 in the mouse retina mimics human retinitis pigmentosa due to mutations in the CRB1 gene.
    Alves CH; Sanz AS; Park B; Pellissier LP; Tanimoto N; Beck SC; Huber G; Murtaza M; Richard F; Sridevi Gurubaran I; Garcia Garrido M; Levelt CN; Rashbass P; Le Bivic A; Seeliger MW; Wijnholds J
    Hum Mol Genet; 2013 Jan; 22(1):35-50. PubMed ID: 23001562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRB2 acts as a modifying factor of CRB1-related retinal dystrophies in mice.
    Pellissier LP; Lundvig DM; Tanimoto N; Klooster J; Vos RM; Richard F; Sothilingam V; Garcia Garrido M; Le Bivic A; Seeliger MW; Wijnholds J
    Hum Mol Genet; 2014 Jul; 23(14):3759-71. PubMed ID: 24565864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy restores vision and delays degeneration in the CNGB1(-/-) mouse model of retinitis pigmentosa.
    Koch S; Sothilingam V; Garcia Garrido M; Tanimoto N; Becirovic E; Koch F; Seide C; Beck SC; Seeliger MW; Biel M; Mühlfriedel R; Michalakis S
    Hum Mol Genet; 2012 Oct; 21(20):4486-96. PubMed ID: 22802073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial.
    Ghazi NG; Abboud EB; Nowilaty SR; Alkuraya H; Alhommadi A; Cai H; Hou R; Deng WT; Boye SL; Almaghamsi A; Al Saikhan F; Al-Dhibi H; Birch D; Chung C; Colak D; LaVail MM; Vollrath D; Erger K; Wang W; Conlon T; Zhang K; Hauswirth W; Alkuraya FS
    Hum Genet; 2016 Mar; 135(3):327-43. PubMed ID: 26825853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV-mediated gene augmentation therapy of CRB1 patient-derived retinal organoids restores the histological and transcriptional retinal phenotype.
    Boon N; Lu X; Andriessen CA; Moustakas I; Buck TM; Freund C; Arendzen CH; Böhringer S; Mei H; Wijnholds J
    Stem Cell Reports; 2023 May; 18(5):1123-1137. PubMed ID: 37084726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancing Gene Therapy for PDE6A Retinitis Pigmentosa.
    Petersen-Jones SM; Occelli LM; Biel M; Michalakis S
    Adv Exp Med Biol; 2019; 1185():103-107. PubMed ID: 31884596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the Crumbs homolog 2 (CRB2) gene and analysis of its role in retinitis pigmentosa and Leber congenital amaurosis.
    van den Hurk JA; Rashbass P; Roepman R; Davis J; Voesenek KE; Arends ML; Zonneveld MN; van Roekel MH; Cameron K; Rohrschneider K; Heckenlively JR; Koenekoop RK; Hoyng CB; Cremers FP; den Hollander AI
    Mol Vis; 2005 Apr; 11():263-73. PubMed ID: 15851977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of mutations in the AIPL1, CRB1, GUCY2D, RPE65, and RPGRIP1 genes in patients with juvenile retinitis pigmentosa.
    Booij JC; Florijn RJ; ten Brink JB; Loves W; Meire F; van Schooneveld MJ; de Jong PT; Bergen AA
    J Med Genet; 2005 Nov; 42(11):e67. PubMed ID: 16272259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human CRB1 and CRB2 form homo- and heteromeric protein complexes in the retina.
    Stehle IF; Imventarza JA; Woerz F; Hoffmann F; Boldt K; Beyer T; Quinn PM; Ueffing M
    Life Sci Alliance; 2024 Jun; 7(6):. PubMed ID: 38570189
    [No Abstract]   [Full Text] [Related]  

  • 13. Genotypic and Phenotypic Characteristics of CRB1-Associated Retinal Dystrophies: A Long-Term Follow-up Study.
    Talib M; van Schooneveld MJ; van Genderen MM; Wijnholds J; Florijn RJ; Ten Brink JB; Schalij-Delfos NE; Dagnelie G; Cremers FPM; Wolterbeek R; Fiocco M; Thiadens AA; Hoyng CB; Klaver CC; Bergen AA; Boon CJF
    Ophthalmology; 2017 Jun; 124(6):884-895. PubMed ID: 28341475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of CRB1-negative Coats-like retinitis pigmentosa.
    Sarao V; Veritti D; Prosperi R; Pignatto S; Lanzetta P
    J AAPOS; 2013 Aug; 17(4):414-6. PubMed ID: 23871396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRB2 Loss in Rod Photoreceptors Is Associated with Progressive Loss of Retinal Contrast Sensitivity.
    Alves CH; Boon N; Mulder AA; Koster AJ; Jost CR; Wijnholds J
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31438467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy into photoreceptors and Müller glial cells restores retinal structure and function in CRB1 retinitis pigmentosa mouse models.
    Pellissier LP; Quinn PM; Alves CH; Vos RM; Klooster J; Flannery JG; Heimel JA; Wijnholds J
    Hum Mol Genet; 2015 Jun; 24(11):3104-18. PubMed ID: 25701872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations.
    Beltran WA; Cideciyan AV; Boye SE; Ye GJ; Iwabe S; Dufour VL; Marinho LF; Swider M; Kosyk MS; Sha J; Boye SL; Peterson JJ; Witherspoon CD; Alexander JJ; Ying GS; Shearman MS; Chulay JD; Hauswirth WW; Gamlin PD; Jacobson SG; Aguirre GD
    Mol Ther; 2017 Aug; 25(8):1866-1880. PubMed ID: 28566226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and Development of AAV-based Gene Supplementation Therapies for Achromatopsia and Retinitis Pigmentosa.
    Schön C; Becirovic E; Biel M; Michalakis S
    Methods Mol Biol; 2018; 1715():33-46. PubMed ID: 29188504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity and Efficacy Evaluation of an Adeno-Associated Virus Vector Expressing Codon-Optimized
    Dufour VL; Cideciyan AV; Ye GJ; Song C; Timmers A; Habecker PL; Pan W; Weinstein NM; Swider M; Durham AC; Ying GS; Robinson PM; Jacobson SG; Knop DR; Chulay JD; Shearman MS; Aguirre GD; Beltran WA
    Hum Gene Ther; 2020 Feb; 31(3-4):253-267. PubMed ID: 31910043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Course of Ocular Function in PRPF31 Retinitis Pigmentosa.
    Hafler BP; Comander J; Weigel DiFranco C; Place EM; Pierce EA
    Semin Ophthalmol; 2016; 31(1-2):49-52. PubMed ID: 26959129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.